14192 Metropolis Ave, Fort Myers, FL 33912, USA 239-245-8223

Doxy-PEP: Doxycycline After Sex for STI Prevention in Fort Myers, FL

Medically reviewed by Sivakumar Raman, MD — Infectious Disease · Reviewed November 2026

Doxy-PEP (doxycycline post-exposure prophylaxis) is a single 200 mg dose of the antibiotic doxycycline taken after sex to reduce the risk of bacterial sexually transmitted infections — syphilis, chlamydia, and gonorrhea. This post-exposure approach is the method supported by clinical trials and recommended in the CDC’s 2024 guidance. At Florida Infectious Disease Care in Fort Myers, our board-certified infectious disease physicians provide Doxy-PEP with same-day appointments, telehealth across Florida, and most major insurance plans accepted.

How Doxy-PEP works

Doxycycline is a well-established, inexpensive antibiotic used safely for decades. Taken soon after condomless sex, it can stop the bacteria that cause syphilis, chlamydia, and gonorrhea from establishing an infection. It does not prevent HIV or other viral infections — for HIV prevention, ask us about PrEP and PEP, which can be prescribed alongside Doxy-PEP as part of a complete prevention plan.

How to take it

Take one 200 mg dose of doxycycline by mouth, ideally within 24 hours and no later than 72 hours after condomless oral, anal, or vaginal sex. If you have sex often, you can take it as often as once a day — but never more than 200 mg in 24 hours. We usually prescribe about 30 doses at a time.

Who should consider Doxy-PEP?

  • Gay and bisexual men, other men who have sex with men, and transgender women who have had gonorrhea, chlamydia, or syphilis in the past 12 months — the group for whom the CDC recommends Doxy-PEP
  • People without a recent STI who are at high risk — a decision made together with your doctor

For cisgender women, Doxy-PEP is not recommended: a study in Kenya did not show a benefit, most likely because many participants did not take the doses as prescribed. A specialist may still discuss it case by case for vaginal sex, as the IAS–USA panel advises. Our specialists will review your history, discuss what the evidence does and does not show for your circumstances, and build a prevention plan around you.

How well does it work?

Across the major studies, Doxy-PEP lowered bacterial STIs by about 47–66% overall. In the three randomized trials the CDC reviewed, syphilis and chlamydia fell by more than 70% and gonorrhea by about half. Across studies, the drop was about 70–88% for chlamydia and syphilis, but gonorrhea is less reliable (about 17–55%), because many gonorrhea strains are already resistant to this family of antibiotics (tetracyclines).

Testing while you use Doxy-PEP

Every 3 to 6 months we test for STIs at every site that may have been exposed and check a syphilis blood test, and we review together whether you still need Doxy-PEP. Doxy-PEP can change how syphilis shows up — both its symptoms and its blood test results — which is one more reason regular testing matters.

If a sex partner has been diagnosed with syphilis, Doxy-PEP is not the treatment for that exposure — contact us, because it is treated differently, usually with a penicillin injection.

Doxy-PEP and antibiotic resistance

Using an antibiotic regularly can help bacteria learn to resist it. Here is what that means for you.

Gonorrhea

  • Doxy-PEP protects less well against gonorrhea, and gonorrhea that resists doxycycline is becoming more common.
  • In the US trial, Doxy-PEP prevented about half of gonorrhea cases (54%). It worked less well in France, where about 75% of gonorrhea strains were already resistant.
  • In King County, Washington, resistant gonorrhea among men who have sex with men rose from about 27% to 70% after local Doxy-PEP guidance was issued in 2023.
  • Experts expect protection against gonorrhea to weaken further as resistance grows.
  • That is why we keep testing every 3 to 6 months at every site that may have been exposed, even while you take Doxy-PEP. Gonorrhea is still treated with a ceftriaxone injection, not doxycycline.

Staph and strep skin bacteria

  • Doxy-PEP can make skin bacteria such as staph (Staphylococcus aureus) and strep more likely to be resistant.
  • In the US trial, by 12 months about 15% of people using Doxy-PEP carried doxycycline-resistant staph.
  • If you get a skin infection, tell your clinician that you take Doxy-PEP, so they can test it (a culture).

Use it only when you need it

Taking Doxy-PEP more often — more than 3 doses a month — was most strongly linked to resistance. Your clinician will review every 3–6 months whether you still need it.

What guidelines say

In the UK, the 2025 national guideline (BASHH) limits Doxy-PEP to preventing syphilis, because of resistance concerns. The US CDC still recommends it and lists resistance as a potential harm. Some experts argue that the benefits outweigh these concerns and favor tracking local resistance instead of limiting use.

Safety and side effects

Doxycycline is generally well tolerated. Because widespread antibiotic use can drive resistance, we prescribe Doxy-PEP thoughtfully and pair it with regular STI testing — this is exactly the kind of stewardship an infectious disease practice is built for.

  • Take doxycycline with a full glass of water and food, and stay upright for at least an hour afterwards. This helps prevent stomach upset and irritation of the esophagus (the food pipe).
  • Doxycycline makes skin burn more easily in the sun — worth knowing in Southwest Florida. Use sunscreen.
  • Take it at least 2 hours apart from dairy products, antacids, and calcium, iron, or magnesium supplements.
  • Any regular (immediate-release) doxycycline works — for Doxy-PEP, for example, two 100 mg tablets. Doses differ between some doxycycline products, so check with your prescriber or pharmacist that your tablets give the right dose. The 40 mg capsule used for rosacea does not work for this.
  • It is not used in pregnancy.
  • Doxycycline does not protect against HIV. If you take HIV PrEP, keep taking it.

What about “Doxy-PrEP” (daily dosing)?

You may see the term Doxy-PrEP for taking doxycycline every day, before exposures, rather than after. It is still being studied: the evidence comes from small pilot trials, no major guideline recommends it, and daily use keeps you on an antibiotic every day — for most people more in total than Doxy-PEP — which raises concerns about antibiotic resistance. Learn more about Doxy-PrEP →

How to get Doxy-PEP in Fort Myers — or anywhere in Florida

Call (239) 245-8223 or book online. We offer same-day appointments, in person at our Fort Myers office or by telehealth anywhere in Florida. Your visit includes a confidential risk assessment, baseline STI testing, and — when appropriate — a prescription you can fill the same day. We accept most major insurance plans, including Medicare, and self-pay patients are welcome. We are open weekdays, with weekend hours for infusion patients.

1. Online Consultation with an Infectious Disease Doctor

2. Easy At-Home Testing

3. PrEP Medication Delivered to Your Doorstep

References

  1. Bachmann LH, Barbee LA, Chan P, et al. CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024. MMWR Recommendations and Reports. 2024;73(2):1-8. ncbi.nlm.nih.gov/pmc/articles/PMC11166373
  2. Harris E. CDC Recommends Doxycycline Prophylaxis to Prevent STIs in US. JAMA. 2024;332(4):273. jamanetwork.com
  3. Gandhi RT, Landovitz RJ, Sax PE, et al. Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel. JAMA. 2025;333(7):609-628. jamanetwork.com
  4. Peters RPH, Grinsztejn B, Celum C, et al. Innovations in the Biomedical Prevention, Diagnosis, and Service Delivery of HIV and Other Sexually Transmitted Infections. The Lancet. 2025;406(10515):2133-2151. pubmed.ncbi.nlm.nih.gov/41176393
  5. Luetkemeyer AF, Donnell D, Cohen SE, et al. Doxycycline to Prevent Bacterial Sexually Transmitted Infections in the USA: Final Results From the DoxyPEP Multicentre, Open-Label, Randomised Controlled Trial and Open-Label Extension. The Lancet Infectious Diseases. 2025;25(8):873-883. pubmed.ncbi.nlm.nih.gov/40147465
  6. Molina JM, Bercot B, Assoumou L, et al. Doxycycline Prophylaxis and Meningococcal Group B Vaccine to Prevent Bacterial Sexually Transmitted Infections in France (ANRS 174 DOXYVAC): A Multicentre, Open-Label, Randomised Trial With a 2 × 2 Factorial Design. The Lancet Infectious Diseases. 2024;24(10):1093-1104. pubmed.ncbi.nlm.nih.gov/38797183
  7. Berçot B, Assoumou L, Caméléna F, et al. Antimicrobial-Resistant Neisseria Gonorrhoeae Infections in Men Using Doxycycline Postexposure Prophylaxis: A Substudy of the ANRS 174 DOXYVAC Trial. Clinical Infectious Diseases. 2026;82(6):1065-1074. pubmed.ncbi.nlm.nih.gov/41208026
  8. Soge OO, Thibault CS, Cannon CA, et al. Potential Impact of Doxycycline Post-Exposure Prophylaxis on Tetracycline Resistance in Neisseria Gonorrhoeae and Colonization With Tetracycline-Resistant Staphylococcus Aureus and Group A Streptococcus. Clinical Infectious Diseases. 2025;80(6):1188-1196. pubmed.ncbi.nlm.nih.gov/40036749
  9. Yechezkel M, Helekal D, Kapadia B, et al. Durability of Doxycycline Effectiveness Against Gonorrhoea After Implementation of Post-Exposure Prophylaxis in Southern California, USA. The Lancet Infectious Diseases. 2026;26(8):819-831. pubmed.ncbi.nlm.nih.gov/42107388
  10. Mittelstaedt R, Kanjilal S, Helekal D, Robbins GK, Grad YH. Staphylococcus Aureus Tetracycline Resistance and Co-Resistance in a Doxycycline Postexposure Prophylaxis-Eligible Population. The Journal of Infectious Diseases. 2025;231(4):e708-e712. pubmed.ncbi.nlm.nih.gov/39718967
  11. Saunders J, Deering J, Dewsnap C, et al. BASHH UK national guideline for the use of doxycycline post-exposure prophylaxis (DoxyPEP) for the prevention of syphilis, 2025. International Journal of STD & AIDS. 2025;36(10):756-764. doi.org/10.1177/09564624251352053
  12. Mishriky F, Chan PA. Antimicrobial Resistance Concerns Should Not Limit Doxycycline Postexposure Prophylaxis Implementation for Bacterial Sexually Transmitted Infection Prevention. Clinical Infectious Diseases. 2026;83(2):285-288. pubmed.ncbi.nlm.nih.gov/41661126
  13. Benson C, Brooks J, Dhanireddy S, et al. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV. Office of AIDS Research Advisory Council. clinicalinfo.hiv.gov
  14. Boschiero MN, Sansone NMS, Matos LR, Marson FAL. Efficacy of Doxycycline as Preexposure and/or Postexposure Prophylaxis to Prevent Sexually Transmitted Diseases: A Systematic Review and Meta-Analysis. Sexually Transmitted Diseases. 2025;52(2):65-72. pubmed.ncbi.nlm.nih.gov/39316078
  15. Grennan T, Mohammed S, Edward J, et al. A Pilot, Randomized Controlled Trial of Dual Daily HIV and Sexually Transmitted Infection Pre-Exposure Prophylaxis Using Tenofovir Disoproxil Fumarate/Emtricitabine and Doxycycline in Gay, Bisexual, and Other Men Who Have Sex With Men and Transgender Women: The DuDHS Study. Clinical Infectious Diseases. 2026;82(6):1054-1062. pubmed.ncbi.nlm.nih.gov/39882974
  16. Chevalier FJ, Bacon O, Johnson KA, Cohen SE. Syphilis: A Review. JAMA. 2025;334(21):1927-1940. doi.org/10.1001/jama.2025.17362

Other Service

Here are our other services we serve as a professional and expert:

Appointments Scheduled at your convenience.

  • Portable Infusion Pump Management
  • Insurance and benefit Verification
  • On Call Infectious Disease Physician
  • Infusion: available 7 days a week
FAQs

Frequently Asked Questions

What is Doxy-PEP?

Doxy-PEP is a single 200 mg dose of doxycycline taken after sex — ideally within 24 hours and no later than 72 hours — to reduce the risk of syphilis, chlamydia, and gonorrhea. The sooner after exposure it's taken, the better it works.

What is the difference between Doxy-PEP and Doxy-PrEP?

Doxy-PEP is taken after a potential exposure — a single dose, ideally within 24 hours and no later than 72 hours. “Doxy-PrEP” refers to taking doxycycline daily, before exposures. Current evidence and CDC guidance support the post-exposure (Doxy-PEP) approach; daily dosing is not a recommended standard and carries greater antibiotic-resistance concerns. Our specialists can explain which approach fits your situation.

How effective is Doxy-PEP?

Across the major studies, syphilis and chlamydia fell by more than 70% and gonorrhea by about half in the trials the CDC reviewed (about 47–66% fewer bacterial STIs overall); the effect on gonorrhea is less reliable because of antibiotic resistance. It does not protect against HIV — ask us about HIV PrEP and PEP for that.

Does Doxy-PEP prevent HIV?

No. Doxy-PEP works only against bacterial STIs. For HIV prevention we prescribe PrEP (daily or long-acting) and, after a possible exposure, PEP — which must be started within 72 hours and is available from us the same day you call during office hours. If our office is closed or we cannot see you today, go to an urgent care center or emergency room now and ask for PEP, then contact us.

Is taking an antibiotic this way safe?

For most patients, yes — doxycycline has decades of safety history. The main considerations are stomach upset, sun sensitivity, and responsible use to limit antibiotic resistance, which is why Doxy-PEP should be prescribed and monitored by a physician rather than improvised. As infectious disease specialists, antibiotic stewardship is central to how we prescribe.

Do I need to be tested before starting?

Yes — we perform baseline STI and HIV testing before starting Doxy-PEP, and while you use it we test for STIs at every site that may have been exposed, with a syphilis blood test, every 3 to 6 months. Regular screening is part of what makes the strategy work and helps us watch for antibiotic resistance.

How much does it cost? Do you take my insurance?

We accept most major insurance plans, including Medicare, and self-pay patients are welcome — doxycycline itself is an inexpensive generic medication. Call (239) 245-8223 and our staff will verify your coverage before your visit.

Can I get Doxy-PEP by telehealth?

Yes — we see patients by video anywhere in Florida, with lab orders sent to a location near you and prescriptions to your pharmacy. Same-week telehealth appointments are usually available, often same-day.

Talk to an infectious disease specialist today

Florida Infectious Disease Care ·
14192 Metropolis Ave, Fort Myers, FL 33912 ·
(239) 245-8223 ·
Open weekdays; weekend hours for infusion patients ·
Same-day appointments ·
Most major insurance accepted ·

Contact us